Company attributes
Location
B2X
CEO
Number of Employees (Ranges)
51 – 2000
Founded Date
2015
Total Funding Amount (USD)
40,000,000
Latest Funding Round Date
April 21, 2021
Latest Funding Type
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
40,000,000
Public/Private
Private0
The company is developing Live biotherapeutics regulated by the FDA (Food and Drug Administration) for indications in the areas of obstetrics, gynecology, lipidology, gastroenterology, and neurology. In consumer health the company is developing scientifically validated probiotics, synbiotics, and microbial innovations across gastroenterology, dermatology, oral hygiene, pediatrics, women's health, and nutrition. Environmental applications include novel applications of bacteria to enhance biodiversity and recover ecosystems disrupted by human activity.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.